Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 3/2019

01-09-2019 | Sarcoidosis | Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Non-infectious Granulomatous Lesions of the Orofacial Region

Author: Susan Müller

Published in: Head and Neck Pathology | Issue 3/2019

Login to get access

Abstract

Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli. Infectious agents, foreign material, systemic inflammation and metabolic disorders can all be associated with granulomatous inflammation. In the orofacial region primary causes of granulomatosis include foreign body reaction, delayed hypersensitivity to topical agents and idiopathic orofacial granulomatosis. Secondary causes of granulomas include infectious agents, sarcoid, and Crohn disease. For this review, infectious causes of orofacial granulomatosis (OFG) including bacteria, parasites and fungi will not be discussed.
Literature
1.
Al-Hamad A, Porter S, Fedele S. Orofacial granulomatosis. Dermatol Clin. 2015;33(3):433–46.CrossRef
2.
Troiano G, Dioguardi M, Giannatempo G, et al. Orofacial granulomatosis: clinical signs of different pathologies. Med Princ Pract. 2015;24(2):117–22.CrossRef
3.
Miest R, Bruce A, Rogers RS. Orofacial granulomatosis. Clin Dermatol. 2016;34(4):505–13.CrossRef
4.
Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis—a 20-year review. Oral Dis. 2009;15(1):46–51.CrossRef
5.
Ito T, Connett JM, Kunkel SL, Matsukawa A. The linkage of innate and adaptive immune response during granulomatous development. Front Immunol. 2013;31:4–10.
6.
Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131–46.CrossRef
7.
Shah KK, Pritt BS, Alexander MP. Histopathologic review of granulomatous inflammation. J Clin Tuberc Other Mycobact Dis. 2017;7:1–12.CrossRef
8.
Wick MR. Granulomatous & histiocytic dermatitides. Semin Diagn Pathol. 2017;34(3):301–311.CrossRef
9.
Fitzpatrick L, Healy CM, McCartan BE, et al. Patch testing for food-associated allergies in orofacial granulomatosis. J Oral Pathol Med. 2011;40(1):10–3.CrossRef
10.
Miest RY, Bruce AJ, Comfere NI, et al. A diagnostic approach to recurrent orofacial swelling: a retrospective study of 104 patients. Mayo Clin Proc. 2017;92(7):1053–1060.CrossRef
11.
Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L. The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med. 2003;32(4):200–5.CrossRef
12.
Gale G, Sigurdsson GV, Östman S, et al. Does Crohn’s disease with concomitant orofacial granulomatosis represent a distinctive disease subtype? Inflamm Bowel Dis. 2016;22(5):1071–7.CrossRef
13.
Marcoval J, Penín RM. Histopathological features of orofacial granulomatosis. Am J Dermatopathol. 2016;38(3):194–200.CrossRef
14.
Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis—a clinical and pathological analysis. Q J Med. 1985;54(213):101–13.PubMed
15.
Melkersson E. Ett fall av recidiverande facialispares i samband med ett angioneurotiskt dem. Vol. 90. Stockholm: Hygiea; 1928. pp. 737e41.
16.
Critchlow WA, Chang D. Cheilitis granulomatosa: a review. Head Neck Pathol. 2014;8(2):209–13.CrossRef
17.
Rogers RS. Granulomatous cheilitis, Melkersson–Rosenthal syndrome, and orofacial granulomatosis. Arch Dermatol. 2000;136(12):1557–8. rd .PubMed
18.
Al Johani K, Moles DR, Hodgson T, Porter SR, Fedele S. Onset and progression of clinical manifestations of orofacial granulomatosis. Oral Dis. 2009;15(3):214–9.CrossRef
19.
Cocuroccia B, Gubinelli E, Annessi G, Zambruno G, Girolomoni G. Persistent unilateral orbital and eyelid oedema as a manifestation of Melkersson–Rosenthal syndrome. J Eur Acad Dermatol Venereol. 2005;19(1):107–11.CrossRef
20.
Rivera-Serrano CM, Man LX, Klein S, Schaitkin BM. Melkersson–Rosenthal syndrome: a facial nerve center perspective. J Plast Reconstr Aesthet Surg. 2014;67(8):1050–4.CrossRef
21.
Kanerva M, Moilanen K, Virolainen S, Vaheri A, Pitkäranta A. Melkersson–Rosenthal syndrome. Otolaryngol Head Neck Surg. 2008;138(2):246–51.CrossRef
22.
Lazzerini M, Martelossi S, Cont G, et al. Orofacial granulomatosis in children: think about Crohn’s disease. Dig Liver Dis. 2015;47(4):338–41.CrossRef
23.
Lazzerini M, Bramuzzo M, Ventura A. Association between orofacial granulomatosis and Crohn’s disease in children: systematic review. World J Gastroenterol. 2014;20(23):7497–504.CrossRef
24.
Bharti R, Wadhwani KK, Tikku AP, Chandra A. Dental amalgam: an update. J Conserv Dent. 2010;13(4):204–8.CrossRef
25.
26.
27.
Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64(1):1–34. quiz 35–6.CrossRef
28.
Eversole R, Tran K, Hansen D, Campbell J. Lip augmentation dermal filler reactions, histopathologic features. Head Neck Pathol. 2013;7(3):241–9.CrossRef
29.
Shahrabi-Farahani S, Lerman MA, Noonan V, Kabani S, Woo SB. Granulomatous foreign body reaction to dermal cosmetic fillers with intraoral migration. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):105–10.CrossRef
30.
Requena C, Requena L, Alegre V, et al. Adverse reaction to silicone simulating orofacial granulomatosis. J Eur Acad Dermatol Venereol. 2015;29(5):998–1001.CrossRef
31.
Feuerstein JD, Cheifetz AS. Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92(7):1088–1103.CrossRef
32.
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42.CrossRef
33.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Dis Mon. 2018;64(2):20–57.CrossRef
34.
Eckel A, Lee D, Deutsch G, Maxin A, Oda D. Oral manifestations as the first presenting sign of Crohn’s disease in a pediatric patient. J Clin Exp Dent. 2017;9(7):e934–8.PubMedPubMedCentral
35.
Woo VL. Oral manifestations of Crohn’s disease: a case report and review of the literature. Case Rep Dent. 2015;2015:830472.PubMedPubMedCentral
36.
Sanderson J, Nunes C, Escudier M, et al. Oro-facial granulomatosis: Crohn’s disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11(9):840–6.CrossRef
37.
Hoekman DR, Diederen K, Benninga MA. Crohn’s disease with orofacial granulomatosis is a distinct disease subtype, or is it? Inflamm Bowel Dis. 2016;22(7):E23.CrossRef
38.
Gale G, Östman S, Rekabdar E, et al. Characterisation of a Swedish cohort with orofacial granulomatosis with or without Crohn’s disease. Oral Dis. 2015;21(1):e98–104.CrossRef
39.
Campbell H, Escudier M, Patel P, et al. Distinguishing orofacial granulomatosis from crohn’s disease: two separate disease entities? Inflamm Bowel Dis. 2011;17(10):2109–15.CrossRef
40.
Haaramo A, Alapulli H, Aine L, et al. Detailed Follow-up Study of Pediatric Orofacial Granulomatosis Patients. J Pediatr Gastroenterol Nutr. 2017;65(4):388–93.CrossRef
41.
Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9(11):227–240.CrossRef
42.
Nico MM, Guimarães AL, Correa PY, Lourenço SV. Oral mucosal lesions in sarcoidosis: comparison with cutaneous lesions. Acta Derm Venereol. 2016;96(3):392–3.CrossRef
43.
James WE, Koutroumpakis E, Saha B, et al. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 2018;154(2):349–56.CrossRef
44.
Bouaziz A, Le Scanff J, Chapelon-Abric C, et al. Oral involvement in sarcoidosis: report of 12 cases. QJM. 2012;105(8):755–67.CrossRef
45.
Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Intern Emerg Med. 2018;13(3):325–31.PubMed
46.
Wessendorf TE, Bonella F, Costabel U. Diagnosis of sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):54–62.CrossRef
Metadata
Title
Non-infectious Granulomatous Lesions of the Orofacial Region
Author
Susan Müller
Publication date
01-09-2019
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 3/2019
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-00997-w

Other articles of this Issue 3/2019

Head and Neck Pathology 3/2019 Go to the issue

Invited Review

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms

Original Paper

Identifying Candidate Biomarkers for Pleomorphic Adenoma: A Case–Control Study

Original Paper

Sclerosing Odontogenic Carcinoma with Local Recurrence: Case Report and Review of Literature

Original Paper

Actinomycosis Presenting as Macroglossia: Case Report and Review of Literature

Letter to the Editor

Microcystic Adenocarcinoma: An Initially Overlooked First Proposal of the Term

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Update on Odontogenic Tumors: Proceedings of the North American Head and Neck Pathology Society